Accord BioPharma is a United States–based company focused on biosimilars and specialty pharmaceuticals that include oncology, immunology, and critical care therapies.
We’re committed to providing treatments that are affordable, accessible, and tailored to the needs of your patients.
Multiple FDA-approved therapies
Several oncology products, including treatments for breast cancer and advanced prostate cancer
A robust pipeline spanning immunology, neurology, and oncology
Fastest
Growing
Intas Pharmaceuticals, the parent company of Accord, is the fastest growing company among the top 10 Indian pharmaceutical firms, with wide reach and dominance in several therapeutic areas, such as oncology, diabetes, and CNS.
Accord also operates outside of the United States as Accord Healthcare, a trusted global biosimilar leader with over 2 decades of experience in the European Union and Asia, with products sold in 85+ countries.
